Release Date: 06/09/12 08:46 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 166.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%